Anthem Biosciences Ltd.
ANTHEM Share PricePharmaceuticals & Drugs
₹759.25
-11.7 (-1.5%)
As on October 3, 2025
Exchange Scrips: BSE544449NSEANTHEMISININE0CZ201020
Market Cap ₹ 42,599 Cr
P/E Ratio 94.07
Dividend Yield N/A
Performance
Market performance
Open772
High773
Volumes2,70,690
Prev759.25
Low756.5
As on2025-10-03
Historical performance
1 Year High873.5
3 Year High873.5
5 Year High873.5
1 Year Low701.9
3 Year Low701.9
5 Year Low701.9
Fundamentals
Company Valuation
Market Cap (₹Cr)
42,599
Face Value (₹)
2
P/E Ratio
94.07
Dividend Yield
N/A
Investment Returns
1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 767.63 | Bearish |
| 10-DMA | 796.31 | Bearish |
| 20-DMA | 814.31 | Bearish |
| 50-DMA | 797.29 | Bearish |
| 100-DMA | --- | |
| 200-DMA | --- |
Shareholding Pattern
| Field | Jul-2025 |
|---|---|
| Promoters | 9 |
| Foreign Investors | --- |
| Domestic Investors | 9 |
| Public Investors | 825835 |
| Government | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 94.07.
- 3Y Stock Price CAGR of the stock is None.
- The stock has a beta of 2.1.
- In the last financial year, the company had an EBITDA of ₹7568 Million.
- The company generated revenue of ₹18446 Million in the previous financial year.
Anthem Biosciences Ltd.
759.25-11.7 (-1.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1039570.1
No. of Shares: 1369 (Approx)
Performance:4%
P/L: ₹39570.1
Top Gainers
| Symbol | Change% |
|---|---|
| ORIENTTECH | 425.15(20%) |
| ATLANTAA | 55.65(20%) |
| AAATECH | 105.28(20%) |
| KIOCL | 528.8(20%) |
| ORISSAMINE | 5656.7(19%) |
Top Losers
| Symbol | Change% |
|---|---|
| CENTUM | 2459.2(-9%) |
| SIGMA | 53.605(-8%) |
| STYLEBAAZA | 354.05(-6%) |
| TATAINVEST | 10002(-6%) |
| EUROTEXIND | 14.65(-5%) |
| UNIMECH | 989.8(-5%) |
| SHANKARA | 178.15(-5%) |
| LCCINFOTEC | 4.71(-5%) |
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent